Related Experiment Video
Updated: Jul 16, 2026

Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice
Published on: February 10, 2013
Prognostic value of dobutamine stress echocardiography in patients with chronic kidney disease
Sébastien Bergeron1, Graham S Hillis, Eric N Haugen
1Division of Cardiovascular Diseases, Mayo Clinic Rochester, MN 55905, USA.
Insights
Dobutamine stress echocardiography (DSE) can predict mortality in chronic kidney disease (CKD) patients. The extent of myocardial ischemia identified by DSE independently predicts all-cause mortality in CKD.
Area of Science:
- Cardiology
- Nephrology
- Medical Diagnostics
Background:
- Dobutamine stress echocardiography (DSE) is recommended for evaluating chronic kidney disease (CKD) patients.
- Limited data exist on the prognostic value of DSE in CKD patients.
Purpose of the Study:
- To assess the prognostic utility of DSE in patients with CKD.
- To determine if DSE can predict mortality in this population.
Main Methods:
- 485 CKD patients (on dialysis or creatinine > 3 mg/mL) underwent DSE.
- Patients were followed for 2.3 +/- 1.8 years for mortality outcomes.
Main Results:
- 39% of patients died during follow-up.
- Extensive ischemia (>25% segments) on DSE was associated with significantly lower survival rates.
- The percentage of ischemic segments was an independent predictor of all-cause mortality (HR 1.40 per 25% increase, P=.001).
- DSE improved the predictive value of clinical models (chi2, 83.6-97.4, P=.003).
Conclusions:
- DSE is a valuable prognostic tool in CKD patients.
- The percentage of ischemic segments on DSE independently predicts mortality.
- DSE provides incremental prognostic information beyond clinical data in CKD.
Background:
Although dobutamine stress echocardiography (DSE) is cited in clinical guidelines for the evaluation of patients with chronic kidney disease (CKD), there are limited data regarding its prognostic utility in this setting. The current study assesses the prognostic value of DSE in patients with CKD.
Methods:
Four hundred eighty-five patients with CKD (on renal dialysis or with creatinine > 3 mg/mL) who had DSE were followed for 2.3 +/- 1.8 years.
Results:
One hundred eighty-eight (39%) patients died during follow-up. Patients with extensive ischemia (affecting > 25% of myocardial segments) had a 1- and 3-year survival rate of 77% and 48%, respectively, compared with 83% and 52% in those with lesser degrees (< or = 25% segments affected) of ischemia and with 88% and 70% in those with a normal DSE. In multivariate analyses, the percentage of ischemic segments on DSE was an independent predictor of all-cause mortality (hazard ratio, 1.40 per 25% increase; 95% CI, 1.16-1.68; P = .001). Inclusion of DSE data improved the predictive value of the best clinical model (chi2, 83.6-97.4; P = .003).
Conclusion:
In patients with CKD, the percentage of ischemic segments during DSE is an independent predictor of mortality and provides prognostic information that is incremental to clinical data.
Related Concept Videos
Chronic Kidney Disease IV: Nursing Management
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Chronic Kidney Disease III: Interprofessional Care
Heart Failure Drugs: Diuretics
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease I: Introduction